Sunday Times (Johannesburg) - June 18, 2006
Futhi Ntshingila
A group of healthcare providers in KwaZulu-Natal has come up with a novel way of teaching illiterate HIV-positive patients about Aids, describing CD4 cells as Zulu warriors and antiretroviral drugs as traditional weapons.
BroadReach Healthcare has coined these and other Zulu expressions to describe the changes in the body after HIV infection, from testing positive to the collapse of the immune system and how anti-HIV medicines work.
The group says it chose the method to reach out to rural communities and to overcome low levels of literacy.
This week BroadReach Healthcare educational consultant Prathima Naidoo told delegates at the third annual US President's Emergency Plan for Aids Relief meeting in Durban that the picture-based communication tool had enabled a rapid roll-out of the antiretroviral programme to patients with varying levels of literacy.
"I think the beauty of it is that they get involved and they use what they know to help understand what is happening to them," said Naidoo. "Knowledge is a powerful thing."
Naidoo said BroadReach devised the method after realising that language differences and low education levels posed a serious threat to teaching patients about adhering to therapy.
She said 10 communities had used the Zulu phrases to help many illiterate patients understand what was happening in their bodies and how to take charge.
"Our training relies on constant interaction with the patients as they craft an evolving story during a three-day workshop," said Naidoo.
HIV-positive Thando Ndlanzi, 31, of Klaarwater, Durban, compared the method to being in a war that she knows she is winning.
She said she almost gave in after her weight plummeted to 45kg, leaving her skeletal.
Now every morning and night Ndlanzi fortifies her warriors with a dosage of antiretrovirals. She now weighs 82kg.
"Most of the terms connected to HIV are in English but now with warriors it makes sense," she said.
060618
ST060607
Copyright © 2006 - The Sunday Times. Reproduction of this article (other than one copy for personal reference) must be cleared through the Sunday Times Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .